- Home
- SNEX vs SPRC Comparison
SNEX vs SPRC Comparison
Compare SNEX & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNEX
- SPRC
- Stock Information
- Founded
- SNEX 1924
- SPRC 2004
- Country
- SNEX United States
- SPRC Israel
- Employees
- SNEX N/A
- SPRC N/A
- Industry
- SNEX Investment Bankers/Brokers/Service
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- SNEX Finance
- SPRC Health Care
- Exchange
- SNEX Nasdaq
- SPRC Nasdaq
- Market Cap
- SNEX 3.3B
- SPRC 2.5M
- IPO Year
- SNEX 1994
- SPRC N/A
- Fundamental
- Price
- SNEX $94.66
- SPRC $0.21
- Analyst Decision
- SNEX
- SPRC
- Analyst Count
- SNEX 0
- SPRC 0
- Target Price
- SNEX N/A
- SPRC N/A
- AVG Volume (30 Days)
- SNEX 173.7K
- SPRC 600.1K
- Earning Date
- SNEX 02-04-2025
- SPRC 02-15-2025
- Dividend Yield
- SNEX N/A
- SPRC N/A
- EPS Growth
- SNEX 6.85
- SPRC N/A
- EPS
- SNEX 7.96
- SPRC N/A
- Revenue
- SNEX $98,704,300,000.00
- SPRC $1,747,000.00
- Revenue This Year
- SNEX N/A
- SPRC N/A
- Revenue Next Year
- SNEX N/A
- SPRC N/A
- P/E Ratio
- SNEX $11.94
- SPRC N/A
- Revenue Growth
- SNEX 64.52
- SPRC N/A
- 52 Week Low
- SNEX $61.68
- SPRC $0.20
- 52 Week High
- SNEX $106.77
- SPRC $6.78
- Technical
- Relative Strength Index (RSI)
- SNEX 37.96
- SPRC 43.06
- Support Level
- SNEX $90.87
- SPRC $0.20
- Resistance Level
- SNEX $103.92
- SPRC $0.24
- Average True Range (ATR)
- SNEX 2.49
- SPRC 0.02
- MACD
- SNEX -1.61
- SPRC -0.00
- Stochastic Oscillator
- SNEX 21.42
- SPRC 14.64
About SNEX StoneX Group Inc.
StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: commercial, Institutional, Retail, and Global Payments. Its customers include governmental and nongovernmental organizations, and commercial banks, brokers, institutional investors, and investment banks. The company operates in United States, South America, Europe, Middle East and Asia and other countries, out of which majority revenue is generates from Middle East and Asia Region.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.